Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Efficacy and Mechanism of Modified Simiao Yongan Decoction Combined With Endovascular Therapy for Diabetic Foot Ulcers (Damp-Heat Toxins Accumulation Syndrome) Based on the Vascular-Immune Microenvironment

NCT07808502 is registered in ClinicalTrials.gov with Chengdu University of Traditional Chinese Medicine as lead sponsor.

NCT NCT07808502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07808502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Efficacy and Mechanism of Modified Simiao Yongan Decoction Combined With Endovascular Therapy for Diabetic Foot Ulcers (Damp-Heat Toxins Accumulation Syndrome) Based on the Vascular-Immune Microenvironment
Lead sponsor
Chengdu University of Traditional Chinese Medicine
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 31, 2026
Completion date
November 30, 2028
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

damp-heat toxins accumulation syndrome, diabetic foot ulcer